What is the Korean Research-based Pharmaceutical Industry Association (KRPIA) in South Korea?

The KRPIA South Korea (Korean Research-based Pharmaceutical Industry Association) is a non-profit organization representing research-driven pharmaceutical companies in the South Korea pharmaceutical industry. Established in 1999 and officially approved in 2000, the association plays a vital role in supporting innovation, promoting ethical practices, and advancing public healthcare.

Currently, KRPIA comprises leading research-based pharmaceutical companies Korea, working together to create an environment where both local and global players can actively contribute to the development of innovative medicines and improve overall quality of life.

The key functions of the KRPIA are:

• Supporting Pharmaceutical Innovation: The KRPIA South Korea supports the development and supply of innovative new pharmaceuticals by creating a conducive environment for local and global pharmaceutical businesses to invest in research and development. The association promotes new drug research and timely delivery of drugs to Korean patients.
• Promoting Ethical Business Practices: The KRPIA aims to promote ethical business practices in the South Korea pharmaceutical industry.
• Enhancing the Pharmaceutical Industry’s Impact on National Health: The association strives to elevate the role of the pharmaceutical industry in improving national health in Korea.
• Providing Up-to-date Drug Information: The KRPIA offers up-to-date drug information to healthcare professionals and the public.
• Advocating for the Industry: The KRPIA advocates for the research-based pharmaceutical companies Korea, advocating for policies that support innovation and growth.
• Improving Patient Access: The association aspires to improve patient access to innovative drugs by leveraging the research and development capabilities and expertise of its member businesses.

Summary 

In summary, the KRPIA South Korea plays a critical role in supporting drug innovation, promoting ethical practices, enhancing healthcare outcomes, and strengthening the overall pharmaceutical ecosystem in the country.

Conclusion

The KRPIA South Korea is a key pillar of the country’s evolving pharmaceutical landscape, helping companies navigate innovation, compliance, and market access.

Are you a research-based pharmaceutical business aiming to develop and launch innovative drugs in South Korea?

Contact us today to find out how our Regulatory Affairs services can help you excel in the South Korea pharmaceutical market.